Enhanced vasoconstriction in sickle cell disease is dependent on ETA receptor activation.
Allan JM, Fox BM, Kasztan M, Kelly GC, Molina PA, King MA, Colson J, Wells L, Bowman L, Blackburn M, Kutlar A, Harris RA, Pollock DM, Pollock JS.
Allan JM, et al. Among authors: bowman l.
Clin Sci (Lond). 2024 Dec 4;138(23):1505-1520. doi: 10.1042/CS20240625.
Clin Sci (Lond). 2024.
PMID: 39526571
Clinical Trial.